Virtual Program

Our 2-day virtual summit, to be held 20-21 September, features thought-provoking plenary sessions, topical presentations and discussions, educational symposia and speakers from a diverse array of backgrounds excited to share with you a wealth of ideas, experiences, and perspectives on the latest HEOR topics in Asia Pacific. 

Special Bonus: Registration includes extended access to all session playback recordings through 21 October 2022.

Note: Times shown within the program are in Korean Standard Time (KST). The Summit will be presented in English without translation.

Recognizing Cultural Diversity in Patient-Centered Outcomes for Healthcare Decision Making

Speaker(s)

Moderator: Ember Lu, PharmD, MS, EMD Serono, Billerica, MA, USA
Speakers: Arinesalingam Gnanasakthy, MSc, MBA, RTI Health Solutions, Research Triangle Park, NC, USA; Jipan Xie, MD, PhD, XL Source Inc, Los Angeles, CA, USA; Andrea Latour, MSc, PRMA Consulting, Singapore, 01, Singapore

Presentation Documents

Across multiple international clinical trials, different effect sizes have been seen in Asian patients compared to their Western country counterparts, especially for endpoints that are self-reported. This leads to challenges in value development and evidence generation, ultimately limiting patient access to potentially highly efficacious products in Asian countries. Previous evidence has showed that this difference could be due to PK/PD or genetic differences in Asian patients. However, another highly impactful variable that is not well understood is the role of cultural diversity.

  • What are the cultural differences that exist and what is their impact?
  • What are the perspectives of the HTA stakeholders in Asia?
  • What are the methodologies that could be implemented to recognize these differences in clinical trials and real-world studies?

Code

ES2